Skip to content

Causes of Delayed Presentation of MI Patients to a Tertiary Care Hospital

Causes of Delayed Presentation of Patients With Myocardial Infarction to a Tertiary Care Hospital: A Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07160556
Acronym
Delay-MI
Enrollment
362
Registered
2025-09-08
Start date
2024-07-01
Completion date
2024-11-01
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DM, HTN-Hypertension, Myocardial Infarction

Keywords

Myocardial Infarction, Delayed presentation, Acute Coronary Syndrome, Cardiovascular Disease

Brief summary

This study is being done to learn more about people who have had a heart attack, also called a myocardial infarction (MI). A heart attack happens when blood flow to the heart muscle is blocked, causing damage. The purpose of this study is to better understand the causes of delayed presentation and effects of the factors that caused delayed presentation. We will collect information about patients' medical history, treatments, and recovery after their heart attack. This information may include blood tests, heart imaging, medications, and lifestyle factors. By studying these patients, we hope to find patterns that can help doctors predict complications, improve treatment, and reduce the chance of another heart attack. The results of this study may help health care providers give better care and guidance to patients and families living with heart disease.

Interventions

OTHERObservational

no intervention was required for this cross sectional study

Sponsors

Bacha Khan Medical College
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years and older with a confirmed diagnosis of myocardial infarction (STEMI or NSTEMI). * Ability to provide informed consent (or consent from a legally authorized representative if patient is incapacitated).

Exclusion criteria

* Severe comorbid illness (e.g., advanced cancer, end-stage renal or liver disease) that may limit survival or affect study outcomes. * Inability to comply with follow-up requirements (e.g., cognitive impairment, lack of contact information, or unwillingness to participate)

Design outcomes

Primary

MeasureTime frameDescription
Number and percentage of MI patients identifying specific barriers (e.g., lack of awareness, distance, transport issues) for delayed hospital presentation, using a researcher-designed structured questionnaire.6 monthsData will be collected using a structured and standardized questionnaire. The questionnaire includes: 1. Sociodemographic data: age, gender, BMI, employment status, past history of MI, and comorbidities. 2. Knowledge of MI symptoms and severity. 3. Pre-hospital details: first medical contact, transportation, and time to hospital. 4. In-hospital details: time to diagnosis and treatment. Responses will be summarized as frequency and percentage distributions for categorical variables (e.g., gender, employment, comorbidities), and mean ± SD for continuous variables (e.g., age, BMI).

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026